A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate
Titel:
A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2 – A GLURP–MSP3 fusion protein malaria vaccine candidate
Auteur:
Lousada-Dietrich, Susana Jogdand, Prajakta S. Jepsen, Søren Pinto, Vera V. Ditlev, Sisse B. Christiansen, Michael Larsen, Severin Olesen Fox, Christopher B. Raman, Vanitha S. Howard, Randall F. Vedvick, Thomas S. Ireton, Gregory Carter, Darrick Reed, Steven G. Theisen, Michael